These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

261 related items for PubMed ID: 20653784

  • 41. The distribution of matrix metalloproteinases and tissue inhibitors of metalloproteinases in the lungs of congenital diaphragmatic hernia patients and age-matched controls.
    Masumoto K, de Rooij JD, Suita S, Rottier R, Tibboel D, de Krijger RR.
    Histopathology; 2006 Apr; 48(5):588-95. PubMed ID: 16623785
    [Abstract] [Full Text] [Related]

  • 42. SRC family kinases mediate epidermal growth factor receptor ligand cleavage, proliferation, and invasion of head and neck cancer cells.
    Zhang Q, Thomas SM, Xi S, Smithgall TE, Siegfried JM, Kamens J, Gooding WE, Grandis JR.
    Cancer Res; 2004 Sep 01; 64(17):6166-73. PubMed ID: 15342401
    [Abstract] [Full Text] [Related]

  • 43. Roles of MMP/TIMP in regulating matrix swelling and cell migration during chick corneal development.
    Huh MI, Lee YM, Seo SK, Kang BS, Chang Y, Lee YS, Fini ME, Kang SS, Jung JC.
    J Cell Biochem; 2007 Aug 01; 101(5):1222-37. PubMed ID: 17295208
    [Abstract] [Full Text] [Related]

  • 44. [Immunohistochemical localization of matrix metalloproteinases (MMP) and tissue inhibitors of metalloproteinases (TIMP) in tuberculous pleuritis].
    Hoheisel G, Sack U, Hui DS, Lai F, Chan KS, Choi CH, Schauer J, Tannapfel A.
    Pneumologie; 2004 May 01; 58(5):305-8. PubMed ID: 15162254
    [Abstract] [Full Text] [Related]

  • 45.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 46. [Role of matrix metalloproteinases-9, 2 and their inhibitor-TIMP-1, 2 in invasive pituitary adenomas biological behavior].
    He DS, Chen MZ, Wang HJ, Ke CL, Yan C, Zheng H, Hong YS.
    Ai Zheng; 2002 Oct 01; 21(10):1124-8. PubMed ID: 12508658
    [Abstract] [Full Text] [Related]

  • 47. Downregulation of vascular matrix metalloproteinase inducer and activator proteins in hypertensive patients.
    Ergul A, Portik-Dobos V, Hutchinson J, Franco J, Anstadt MP.
    Am J Hypertens; 2004 Sep 01; 17(9):775-82. PubMed ID: 15363819
    [Abstract] [Full Text] [Related]

  • 48.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 49.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 50. Tumor necrosis factor-alpha-stimulated membrane type 1-matrix metalloproteinase production is modulated by epidermal growth factor receptor signaling in human gingival fibroblasts.
    Smith PC, Guerrero J, Tobar N, Cáceres M, González MJ, Martínez J.
    J Periodontal Res; 2009 Feb 01; 44(1):73-80. PubMed ID: 19515020
    [Abstract] [Full Text] [Related]

  • 51. Immunohistochemical expression of MMP-9, TIMP-2, E-cadherin and vimentin in ameloblastomas and their implication in the local aggressive behavior of these tumors.
    Florescu A, Mărgăritescu C, Simionescu CE, Stepan A.
    Rom J Morphol Embryol; 2012 Feb 01; 53(4):975-84. PubMed ID: 23303021
    [Abstract] [Full Text] [Related]

  • 52.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 53. Invadopodia proteins, cortactin, N-WASP and WIP differentially promote local invasiveness in ameloblastoma.
    Siar CH, Rahman ZA, Tsujigiwa H, Mohamed Om Alblazi K, Nagatsuka H, Ng KH.
    J Oral Pathol Med; 2016 Sep 01; 45(8):591-8. PubMed ID: 26752341
    [Abstract] [Full Text] [Related]

  • 54. Role of hypoxia-related proteins in invasion of ameloblastoma cells: crosstalk between NOTCH1, hypoxia-inducible factor 1α, a disintegrin and metalloproteinase 12, and heparin-binding epidermal growth factor.
    da Costa NM, Fialho AD, Proietti CC, da Silva Kataoka MS, Jaeger RG, de Alves-Júnior SM, de Jesus Viana Pinheiro J.
    Histopathology; 2016 Jul 01; 69(1):99-106. PubMed ID: 26707922
    [Abstract] [Full Text] [Related]

  • 55. The imbalance between metalloproteinases and their tissue inhibitors is involved in the pathogenesis of dermatitis herpetiformis.
    Zebrowska A, Narbutt J, Sysa-Jedrzejowska A, Kobos J, Waszczykowska E.
    Mediators Inflamm; 2005 Dec 14; 2005(6):373-9. PubMed ID: 16489258
    [Abstract] [Full Text] [Related]

  • 56.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 57. [Correlations of extrocellular matrix metalloproteinase inducer and microvessel density to invasiveness of ameloblastoma].
    Jiang LJ, Shao CK, He D, Li WG, Wu XZ, Cai DZ.
    Ai Zheng; 2008 Dec 14; 27(12):1263-6. PubMed ID: 19079990
    [Abstract] [Full Text] [Related]

  • 58.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 59. TGF-β1, Smad-2/-3, Smad-1/-5/-8, and Smad-4 signaling factors are expressed in ameloblastomas, adenomatoid odontogenic tumors, and calcifying cystic odontogenic tumors: an immunohistochemical study.
    Karathanasi V, Tosios KI, Nikitakis NG, Piperi E, Koutlas I, Trimis G, Sklavounou A.
    J Oral Pathol Med; 2013 May 14; 42(5):415-23. PubMed ID: 23157422
    [Abstract] [Full Text] [Related]

  • 60. Immunohistochemical detection of matrix metalloproteinases (MMPs) and tissue inhibitors of metalloproteinases (TIMPs) in ameloblastomas.
    Kumamoto H, Yamauchi K, Yoshida M, Ooya K.
    J Oral Pathol Med; 2003 Feb 14; 32(2):114-20. PubMed ID: 12542835
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 14.